Chemfab Alkalis Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 13, 2025, 12:45 am

Market Cap	1,185 Cr.
Current Price	837
High / Low	1,230/500
Stock P/E	66.4
Book Value	279
Dividend Yield	0.15 %
ROCE	11.2 %
ROE	7.88 %
Face Value	10.0
PEG Ratio	0.82

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Chemfab Alkalis Ltd

Competitors of Chemfab Alkalis Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Caprolactam Chemicals Ltd	19.8 Cr.	43.0	65.0/38.2		11.6	0.00 %	6.86 %	3.67 %	10.0
Standard Industries Ltd	126 Cr.	19.5	39.0/17.5	135	20.1	5.38 %	6.83 %	6.28 %	5.00
Gujarat Alkalies & Chemicals Ltd	4,637 Cr.	632	900/484		842	0.00 %	3.83 %	3.88 %	10.0
GHCL Ltd	5,806 Cr.	606	779/475	9.30	364	1.98 %	25.1 %	19.3 %	10.0
Tata Chemicals Ltd	21,619 Cr.	849	1,247/756	81.1	847	1.77 %	4.15 %	1.22 %	10.0
Industry Average	6,674.60 Cr	497.75		72.95	393.95	1.55%	9.66%	7.04%	9.17

All Competitor Stocks of Chemfab Alkalis Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	77.74	88.10	98.11	76.01	83.94	73.30	79.08	79.58	86.33	82.30	76.04	79.00	79.21
Expenses	55.38	68.63	62.58	49.98	58.40	48.19	63.14	67.44	69.94	69.13	65.59	66.34	64.72
Operating Profit	22.36	19.47	35.53	26.03	25.54	25.11	15.94	12.14	16.39	13.17	10.45	12.66	14.49
OPM %	28.76%	22.10%	36.21%	34.25%	30.43%	34.26%	20.16%	15.26%	18.99%	16.00%	13.74%	16.03%	18.29%
Other Income	0.54	2.97	0.64	-2.25	2.10	1.45	3.58	1.19	1.25	1.76	2.57	0.59	1.42
Interest	0.09	0.07	0.12	0.04	0.04	0.04	0.04	0.06	0.43	0.41	0.51	1.22	1.63
Depreciation	5.73	5.85	5.89	5.85	5.71	5.44	5.39	5.59	5.40	5.47	6.41	7.82	8.51
Profit before tax	17.08	16.52	30.16	17.89	21.89	21.08	14.09	7.68	11.81	9.05	6.10	4.21	5.77
Tax %	29.45%	21.91%	28.88%	26.05%	28.32%	24.86%	29.67%	30.34%	30.91%	27.40%	29.18%	29.93%	30.16%
Net Profit	12.05	12.90	21.46	13.23	15.68	15.84	9.91	5.35	8.16	6.56	4.33	2.95	4.02
EPS in Rs	8.56	9.13	15.18	9.36	11.09	11.17	6.98	3.77	5.74	4.61	3.03	2.06	2.81

Last Updated: March 3, 2025, 5:00 pm

Below is a detailed analysis of the quarterly data for Chemfab Alkalis Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 79.21 Cr.. The value appears strong and on an upward trend. It has increased from 79.00 Cr. (Sep 2024) to 79.21 Cr., marking an increase of 0.21 Cr..
For Expenses, as of Dec 2024, the value is 64.72 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 66.34 Cr. (Sep 2024) to 64.72 Cr., marking a decrease of 1.62 Cr..
For Operating Profit, as of Dec 2024, the value is 14.49 Cr.. The value appears strong and on an upward trend. It has increased from 12.66 Cr. (Sep 2024) to 14.49 Cr., marking an increase of 1.83 Cr..
For OPM %, as of Dec 2024, the value is 18.29%. The value appears strong and on an upward trend. It has increased from 16.03% (Sep 2024) to 18.29%, marking an increase of 2.26%.
For Other Income, as of Dec 2024, the value is 1.42 Cr.. The value appears strong and on an upward trend. It has increased from 0.59 Cr. (Sep 2024) to 1.42 Cr., marking an increase of 0.83 Cr..
For Interest, as of Dec 2024, the value is 1.63 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.22 Cr. (Sep 2024) to 1.63 Cr., marking an increase of 0.41 Cr..
For Depreciation, as of Dec 2024, the value is 8.51 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7.82 Cr. (Sep 2024) to 8.51 Cr., marking an increase of 0.69 Cr..
For Profit before tax, as of Dec 2024, the value is 5.77 Cr.. The value appears strong and on an upward trend. It has increased from 4.21 Cr. (Sep 2024) to 5.77 Cr., marking an increase of 1.56 Cr..
For Tax %, as of Dec 2024, the value is 30.16%. The value appears to be increasing, which may not be favorable. It has increased from 29.93% (Sep 2024) to 30.16%, marking an increase of 0.23%.
For Net Profit, as of Dec 2024, the value is 4.02 Cr.. The value appears strong and on an upward trend. It has increased from 2.95 Cr. (Sep 2024) to 4.02 Cr., marking an increase of 1.07 Cr..
For EPS in Rs, as of Dec 2024, the value is 2.81. The value appears strong and on an upward trend. It has increased from 2.06 (Sep 2024) to 2.81, marking an increase of 0.75.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:35 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	10	21	30	25	140	180	193	205	181	272	331	327	317
Expenses	13	23	29	18	108	128	133	149	157	215	219	269	266
Operating Profit	-4	-3	0	7	32	52	61	56	24	57	112	58	51
OPM %	-37%	-13%	1%	27%	23%	29%	31%	27%	13%	21%	34%	18%	16%
Other Income	0	3	3	0	2	4	-15	-0	1	6	2	8	6
Interest	7	8	7	3	5	4	2	4	3	1	1	1	4
Depreciation	3	3	4	4	13	12	15	25	20	22	23	22	28
Profit before tax	-14	-10	-7	0	16	40	28	27	2	39	91	43	25
Tax %	0%	0%	0%	0%	6%	36%	41%	5%	479%	26%	27%	30%
Net Profit	-14	-10	-7	0	16	25	17	26	-8	29	66	30	18
EPS in Rs						18.42	12.07	18.36	-5.72	20.40	46.69	21.08	12.51
Dividend Payout %	0%	0%	0%	0%	11%	7%	10%	7%	0%	6%	3%	6%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	28.57%	30.00%	100.00%	56.25%	-32.00%	52.94%	-130.77%	462.50%	127.59%	-54.55%
Change in YoY Net Profit Growth (%)	0.00%	1.43%	70.00%	-43.75%	-88.25%	84.94%	-183.71%	593.27%	-334.91%	-182.13%

Chemfab Alkalis Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	32%
5 Years:	11%
3 Years:	22%
TTM:	-1%

Compounded Profit Growth
10 Years:	17%
5 Years:	1%
3 Years:	79%
TTM:	-55%

Stock Price CAGR
10 Years:	%
5 Years:	45%
3 Years:	67%
1 Year:	52%

Return on Equity
10 Years:	%
5 Years:	10%
3 Years:	13%
Last Year:	8%

Last Updated: Unknown

Balance Sheet

Last Updated: March 14, 2025, 3:55 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	5	5	5	7	14	14	14	14	14	14	14	14	14
Reserves	-6	-17	-24	-17	201	222	237	262	254	284	349	379	385
Borrowings	69	76	82	66	16	23	34	43	31	9	2	20	81
Other Liabilities	8	10	10	14	44	39	36	30	36	45	48	85	61
Total Liabilities	76	75	73	70	275	298	321	348	335	352	413	498	540
Fixed Assets	68	64	61	57	164	173	194	195	202	194	191	181	258
CWIP	0	0	0	1	11	2	10	35	3	7	14	57	7
Investments	0	0	0	0	0	0	0	8	31	42	110	110	149
Other Assets	8	10	12	12	99	124	117	110	98	109	98	150	127
Total Assets	76	75	73	70	275	298	321	348	335	352	413	498	540

Below is a detailed analysis of the balance sheet data for Chemfab Alkalis Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
For Reserves, as of Sep 2024, the value is ₹385.00 Cr.. The value appears strong and on an upward trend. It has increased from 379.00 Cr. (Mar 2024) to ₹385.00 Cr., marking an increase of 6.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹81.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 20.00 Cr. (Mar 2024) to ₹81.00 Cr., marking an increase of 61.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹61.00 Cr.. The value appears to be improving (decreasing). It has decreased from 85.00 Cr. (Mar 2024) to ₹61.00 Cr., marking a decrease of 24.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹540.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 498.00 Cr. (Mar 2024) to ₹540.00 Cr., marking an increase of 42.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹258.00 Cr.. The value appears strong and on an upward trend. It has increased from 181.00 Cr. (Mar 2024) to ₹258.00 Cr., marking an increase of 77.00 Cr..
For CWIP, as of Sep 2024, the value is ₹7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Mar 2024) to ₹7.00 Cr., marking a decrease of 50.00 Cr..
For Investments, as of Sep 2024, the value is ₹149.00 Cr.. The value appears strong and on an upward trend. It has increased from 110.00 Cr. (Mar 2024) to ₹149.00 Cr., marking an increase of 39.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹127.00 Cr.. The value appears to be declining and may need further review. It has decreased from 150.00 Cr. (Mar 2024) to ₹127.00 Cr., marking a decrease of 23.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹540.00 Cr.. The value appears strong and on an upward trend. It has increased from 498.00 Cr. (Mar 2024) to ₹540.00 Cr., marking an increase of 42.00 Cr..

Notably, the Reserves (385.00 Cr.) exceed the Borrowings (81.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	-14	-0	-1	38	44	41	54	46	55	97	52
Cash from Investing Activity +	2	-1	-1	-9	-30	-47	-58	-7	-21	-52	-130
Cash from Financing Activity +	10	1	0	-30	-13	6	3	-16	-25	-9	16
Net Cash Flow	-2	-0	-2	-1	1	0	-1	23	9	36	-62

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-73.00	-79.00	-82.00	-59.00	16.00	29.00	27.00	13.00	-7.00	48.00	110.00	38.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	48	49	42	9	22	35	31	17	31	29	24	24
Inventory Days	250	341	320	203			152	84	79	54	89	58
Days Payable	32	320	64	546			225	164	156	92	145	101
Cash Conversion Cycle	266	70	298	-334	22	35	-43	-63	-47	-9	-32	-20
Working Capital Days	-355	-177	-166	-329	-24	-3	10	23	30	15	8	-26
ROCE %	-10%	-4%	-0%	6%	15%	17%	18%	11%	2%	13%	28%	11%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	73.36%	73.35%	73.34%	73.30%	73.11%	73.11%	72.99%	72.88%	72.88%	72.88%	72.63%	72.56%
FIIs	0.02%	0.00%	0.38%	0.31%	0.39%	0.28%	0.24%	0.29%	0.35%	0.27%	0.11%	0.03%
DIIs	0.07%	0.08%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.27%
Government	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.03%	0.03%	0.00%	0.00%	0.00%
Public	26.55%	26.58%	26.21%	26.31%	26.43%	26.54%	26.71%	26.73%	26.65%	26.77%	27.20%	27.12%
No. of Shareholders	7,487	7,560	8,748	9,562	9,856	11,098	12,136	11,745	12,624	11,704	12,536	12,430

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	18.53	45.61	20.36	-5.81	18.27
Diluted EPS (Rs.)	18.34	45.14	20.36	-5.81	18.16
Cash EPS (Rs.)	34.21	61.71	36.06	8.60	36.27
Book Value[Excl.RevalReserv]/Share (Rs.)	271.92	254.72	210.84	190.09	197.67
Book Value[Incl.RevalReserv]/Share (Rs.)	271.92	254.72	210.84	190.09	197.67
Revenue From Operations / Share (Rs.)	230.06	233.65	192.16	128.60	146.77
PBDIT / Share (Rs.)	43.89	81.79	44.10	17.57	41.74
PBIT / Share (Rs.)	28.18	65.62	28.38	3.18	23.73
PBT / Share (Rs.)	27.52	63.06	27.66	1.44	19.17
Net Profit / Share (Rs.)	18.50	45.54	20.34	-5.78	18.26
NP After MI And SOA / Share (Rs.)	18.50	45.54	20.34	-5.78	18.26
PBDIT Margin (%)	19.07	35.00	22.95	13.65	28.43
PBIT Margin (%)	12.24	28.08	14.77	2.47	16.17
PBT Margin (%)	11.96	26.99	14.39	1.12	13.06
Net Profit Margin (%)	8.04	19.49	10.58	-4.49	12.44
NP After MI And SOA Margin (%)	8.04	19.49	10.58	-4.49	12.44
Return on Networth / Equity (%)	6.80	17.87	9.64	-3.04	9.23
Return on Capital Employeed (%)	9.81	25.41	13.30	1.52	11.04
Return On Assets (%)	5.26	15.67	8.16	-2.42	7.30
Long Term Debt / Equity (X)	0.04	0.00	0.00	0.08	0.07
Total Debt / Equity (X)	0.04	0.00	0.02	0.11	0.15
Asset Turnover Ratio (%)	0.71	0.86	0.79	0.52	0.00
Current Ratio (X)	1.09	2.71	1.82	1.83	1.04
Quick Ratio (X)	0.92	2.34	1.58	1.60	0.86
Inventory Turnover Ratio (X)	4.47	3.36	4.62	2.85	0.00
Dividend Payout Ratio (NP) (%)	6.73	2.73	0.00	0.00	6.84
Dividend Payout Ratio (CP) (%)	3.64	2.01	0.00	0.00	3.44
Earning Retention Ratio (%)	93.27	97.27	0.00	0.00	93.16
Cash Earning Retention Ratio (%)	96.36	97.99	0.00	0.00	96.56
Interest Coverage Ratio (X)	66.27	473.83	61.54	10.07	18.46
Interest Coverage Ratio (Post Tax) (X)	28.94	278.63	29.38	-2.32	10.10
Enterprise Value (Cr.)	916.08	314.58	353.32	204.65	169.20
EV / Net Operating Revenue (X)	2.80	0.94	1.30	1.13	0.82
EV / EBITDA (X)	14.67	2.71	5.67	8.29	2.91
MarketCap / Net Operating Revenue (X)	2.82	0.96	1.30	0.97	0.63
Retention Ratios (%)	93.26	97.26	0.00	0.00	93.15
Price / BV (X)	2.38	0.88	1.19	0.66	0.47
Price / Net Operating Revenue (X)	2.82	0.96	1.30	0.97	0.63
EarningsYield	0.02	0.20	0.08	-0.04	0.19

After reviewing the key financial ratios for Chemfab Alkalis Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 18.53. This value is within the healthy range. It has decreased from 45.61 (Mar 23) to 18.53, marking a decrease of 27.08.
For Diluted EPS (Rs.), as of Mar 24, the value is 18.34. This value is within the healthy range. It has decreased from 45.14 (Mar 23) to 18.34, marking a decrease of 26.80.
For Cash EPS (Rs.), as of Mar 24, the value is 34.21. This value is within the healthy range. It has decreased from 61.71 (Mar 23) to 34.21, marking a decrease of 27.50.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 271.92. It has increased from 254.72 (Mar 23) to 271.92, marking an increase of 17.20.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 271.92. It has increased from 254.72 (Mar 23) to 271.92, marking an increase of 17.20.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 230.06. It has decreased from 233.65 (Mar 23) to 230.06, marking a decrease of 3.59.
For PBDIT / Share (Rs.), as of Mar 24, the value is 43.89. This value is within the healthy range. It has decreased from 81.79 (Mar 23) to 43.89, marking a decrease of 37.90.
For PBIT / Share (Rs.), as of Mar 24, the value is 28.18. This value is within the healthy range. It has decreased from 65.62 (Mar 23) to 28.18, marking a decrease of 37.44.
For PBT / Share (Rs.), as of Mar 24, the value is 27.52. This value is within the healthy range. It has decreased from 63.06 (Mar 23) to 27.52, marking a decrease of 35.54.
For Net Profit / Share (Rs.), as of Mar 24, the value is 18.50. This value is within the healthy range. It has decreased from 45.54 (Mar 23) to 18.50, marking a decrease of 27.04.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 18.50. This value is within the healthy range. It has decreased from 45.54 (Mar 23) to 18.50, marking a decrease of 27.04.
For PBDIT Margin (%), as of Mar 24, the value is 19.07. This value is within the healthy range. It has decreased from 35.00 (Mar 23) to 19.07, marking a decrease of 15.93.
For PBIT Margin (%), as of Mar 24, the value is 12.24. This value is within the healthy range. It has decreased from 28.08 (Mar 23) to 12.24, marking a decrease of 15.84.
For PBT Margin (%), as of Mar 24, the value is 11.96. This value is within the healthy range. It has decreased from 26.99 (Mar 23) to 11.96, marking a decrease of 15.03.
For Net Profit Margin (%), as of Mar 24, the value is 8.04. This value is within the healthy range. It has decreased from 19.49 (Mar 23) to 8.04, marking a decrease of 11.45.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 8.04. This value is within the healthy range. It has decreased from 19.49 (Mar 23) to 8.04, marking a decrease of 11.45.
For Return on Networth / Equity (%), as of Mar 24, the value is 6.80. This value is below the healthy minimum of 15. It has decreased from 17.87 (Mar 23) to 6.80, marking a decrease of 11.07.
For Return on Capital Employeed (%), as of Mar 24, the value is 9.81. This value is below the healthy minimum of 10. It has decreased from 25.41 (Mar 23) to 9.81, marking a decrease of 15.60.
For Return On Assets (%), as of Mar 24, the value is 5.26. This value is within the healthy range. It has decreased from 15.67 (Mar 23) to 5.26, marking a decrease of 10.41.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.04. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 23) to 0.04, marking an increase of 0.04.
For Total Debt / Equity (X), as of Mar 24, the value is 0.04. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 0.04, marking an increase of 0.04.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.71. It has decreased from 0.86 (Mar 23) to 0.71, marking a decrease of 0.15.
For Current Ratio (X), as of Mar 24, the value is 1.09. This value is below the healthy minimum of 1.5. It has decreased from 2.71 (Mar 23) to 1.09, marking a decrease of 1.62.
For Quick Ratio (X), as of Mar 24, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 2.34 (Mar 23) to 0.92, marking a decrease of 1.42.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.47. This value is within the healthy range. It has increased from 3.36 (Mar 23) to 4.47, marking an increase of 1.11.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 6.73. This value is below the healthy minimum of 20. It has increased from 2.73 (Mar 23) to 6.73, marking an increase of 4.00.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 3.64. This value is below the healthy minimum of 20. It has increased from 2.01 (Mar 23) to 3.64, marking an increase of 1.63.
For Earning Retention Ratio (%), as of Mar 24, the value is 93.27. This value exceeds the healthy maximum of 70. It has decreased from 97.27 (Mar 23) to 93.27, marking a decrease of 4.00.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 96.36. This value exceeds the healthy maximum of 70. It has decreased from 97.99 (Mar 23) to 96.36, marking a decrease of 1.63.
For Interest Coverage Ratio (X), as of Mar 24, the value is 66.27. This value is within the healthy range. It has decreased from 473.83 (Mar 23) to 66.27, marking a decrease of 407.56.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 28.94. This value is within the healthy range. It has decreased from 278.63 (Mar 23) to 28.94, marking a decrease of 249.69.
For Enterprise Value (Cr.), as of Mar 24, the value is 916.08. It has increased from 314.58 (Mar 23) to 916.08, marking an increase of 601.50.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.80. This value is within the healthy range. It has increased from 0.94 (Mar 23) to 2.80, marking an increase of 1.86.
For EV / EBITDA (X), as of Mar 24, the value is 14.67. This value is within the healthy range. It has increased from 2.71 (Mar 23) to 14.67, marking an increase of 11.96.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.82. This value is within the healthy range. It has increased from 0.96 (Mar 23) to 2.82, marking an increase of 1.86.
For Retention Ratios (%), as of Mar 24, the value is 93.26. This value exceeds the healthy maximum of 70. It has decreased from 97.26 (Mar 23) to 93.26, marking a decrease of 4.00.
For Price / BV (X), as of Mar 24, the value is 2.38. This value is within the healthy range. It has increased from 0.88 (Mar 23) to 2.38, marking an increase of 1.50.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.82. This value is within the healthy range. It has increased from 0.96 (Mar 23) to 2.82, marking an increase of 1.86.
For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.20 (Mar 23) to 0.02, marking a decrease of 0.18.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Chemfab Alkalis Ltd as of May 12, 2025 is: 1,169.61

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of May 12, 2025, Chemfab Alkalis Ltd is Undervalued by 39.74% compared to the current share price 837.00

Intrinsic Value of Chemfab Alkalis Ltd as of May 12, 2025 is: 2,112.70

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of May 12, 2025, Chemfab Alkalis Ltd is Undervalued by 152.41% compared to the current share price 837.00

Last 5 Year EPS CAGR: 80.63%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -82.83, which is a positive sign. The company has higher reserves (193.00 cr) compared to borrowings (42.46 cr), indicating strong financial stability. The company has shown consistent growth in sales (171.69 cr) and profit (21.54 cr) over the years.	The stock has a low average ROCE of 8.92%, which may not be favorable. The stock has a high average Cash Conversion Cycle of 11.92, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chemfab Alkalis Ltd:
1. Net Profit Margin: 8.04%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 9.81% (Industry Average ROCE: 9.66%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 6.8% (Industry Average ROE: 7.04%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 28.94
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.92
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 66.4 (Industry average Stock P/E: 48.63)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.04
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Chemfab Alkalis Ltd. is a Public Limited Listed company incorporated on 06/05/2009 and has its registered office in the State of Tamil Nadu, India. Company's Corporate Identification Number(CIN) is L24290TN2009PLC071563 and registration number is 071563. Currently company belongs to the Industry of Chemicals - Inorganic - Caustic Soda/Soda Ash. Company's Total Operating Revenue is Rs. 327.29 Cr. and Equity Capital is Rs. 14.23 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Inorganic - Caustic Soda/Soda Ash	Team House, GST Salai, Chennai (Madras) Tamil Nadu 600048	chemfabmktg@ccal.in http://www.chemfabalkalis.com

Management
Name	Position Held
Mr. Suresh Krishnamurthi Rao	Chairman & Non-Exe.Director
Mr. C S Ramesh	Non Executive Director
Mr. R Mahendran	Non Executive Director
Mr. Nitin S Cowlagi	Non Executive Director
Mrs. Sujatha Jayarajan	Independent Director
Mr. A Janakiraman	Independent Director
Mrs. Drushti Desai	Independent Director
Mr. T Ramabadhran	Independent Director

FAQ

What is the intrinsic value of Chemfab Alkalis Ltd?

Chemfab Alkalis Ltd's intrinsic value (as of 12 May 2025) is ₹1169.61 — 39.74% higher the current market price of 837.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 1,185 Cr. market cap, FY2025-2026 high/low of ₹1,230/500, reserves of 385 Cr, and liabilities of 540 Cr.

What is the Market Cap of Chemfab Alkalis Ltd?

The Market Cap of Chemfab Alkalis Ltd is 1,185 Cr..

What is the current Stock Price of Chemfab Alkalis Ltd as on 12 May 2025?

The current stock price of Chemfab Alkalis Ltd as on 12 May 2025 is 837.

What is the High / Low of Chemfab Alkalis Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Chemfab Alkalis Ltd stocks is ₹1,230/500.

What is the Stock P/E of Chemfab Alkalis Ltd?

The Stock P/E of Chemfab Alkalis Ltd is 66.4.

What is the Book Value of Chemfab Alkalis Ltd?

The Book Value of Chemfab Alkalis Ltd is 279.

What is the Dividend Yield of Chemfab Alkalis Ltd?

The Dividend Yield of Chemfab Alkalis Ltd is 0.15 %.

What is the ROCE of Chemfab Alkalis Ltd?

The ROCE of Chemfab Alkalis Ltd is 11.2 %.

What is the ROE of Chemfab Alkalis Ltd?

The ROE of Chemfab Alkalis Ltd is 7.88 %.

What is the Face Value of Chemfab Alkalis Ltd?

The Face Value of Chemfab Alkalis Ltd is 10.0.